COVID-19 vaccine study for children and adults
Part of Infections, Lungs & breathing clinical trials.
This study tests a COVID-19 vaccine in children and adults. It may help protect against COVID-19.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 5 years old or older.
- If you are 5 to 64 years old, you need at least one medical condition that increases your risk of severe COVID-19.
- You must not have had a severe allergic reaction to any vaccine or its ingredients.
- You must not have a history of myocarditis or pericarditis.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a COVID-19 vaccine in healthy adults to see how well it works. It may be an option if you are not at higher risk for severe COVID-19 and have not had COVID-19 in the past 6 months.
This study tests a new mRNA vaccine (called mRNA-1283) to protect against COVID-19 in children from 6 months to under 12 years old. It aims to see if the vaccine is safe and produces a good immune response.
This study follows adults who have already received a COVID-19 vaccine to monitor side effects and safety over time. Your participation helps researchers understand how the vaccine affects different people who are at higher risk due to their work.
This study tests an updated mRNA COVID-19 vaccine to see how well it boosts immunity and how safe it is. It may help protect you from severe COVID-19 if you are older or have certain health conditions.
This study tests a new type of COVID-19 vaccine that is designed to train your immune system to make stronger, longer-lasting protection. You may be able to join if you are 40–64, have already had at least two doses of a mRNA COVID-19 vaccine (Pfizer or Moderna) more than 4 months ago, and are generally healthy.
This trial tests updated COVID-19 vaccines designed to better protect against current variants. It's for people who have already been vaccinated and are at higher risk for severe COVID-19.
Hear when a new COVID-19 Vaccines trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.